Back to Results
First PageMeta Content
Biology / Microbiology / Cervarix / HPV vaccine / Gardasil / Human papillomavirus / Cervical cancer / Wart / AS04 / Papillomavirus / Medicine / Vaccines


Date: July 14, 2011 From:
Add to Reading List

Open Document

File Size: 371,50 KB

Share Result on Facebook

Company

GlaxoSmithKline / Merck / Studies [CBER generated] Study Number Study HPV048 Group / Bioresearch Monitoring Page / Glaxosmithkline plc / Clinical Review Branch / /

Country

Germany / United States / Canada / Australia / United Kingdom / /

Event

FDA Phase / /

IndustryTerm

prevention of the following diseases / prevention of cervical precancers and cancers / /

MedicalCondition

cancers / cancer / disease / headache / HPV / nausea / cervical intraepithelial neoplasia / genital warts / urticaria / diseases / CIN / infection / dizziness / infections / Sexually transmitted diseases / adenocarcinoma / /

MedicalTreatment

Immunization / vaccination / /

Organization

Review Center for Biologics Evaluation / Vaccines Research and Review Center for Biologics Evaluation and Research Food and Drug Administration Subject / World Health Organization / Food and Drug Administration / European Commission / Division of Vaccines / Vaccines and Related Products Applications office of Vaccines Research / Centers for Disease Control and Prevention / /

Person

Lewis K. Schrager / Michael Ngyuen / Michael Nguyen / Nancy B. Miller / /

/

Position

statistician / Executive / physician / General Information 1.1 Medical Officer / Medical Officer / General / biostatistician / M.D. Medical Officer / M.D. Chief / 2 Division / /

Product

sodium chloride / to / HPV-048 / /

ProvinceOrState

Indiana / /

PublishedMedium

the Clinical Review / /

Technology

alpha / jsp / /

URL

www.ema.europa.eu / http /

SocialTag